Cataract remains the most common causes of blindness worldwide, followed by uncorrected refractive error, glaucoma, age-related macular degeneration (AMD), cornea-related diseases, trachoma and diabetic retinopathy, researchers believe.
Ciclosporin A Cationic Emulsion (CsA CE; Ikervis, Santen) significantly improved signs and symptoms of dry eye disease in a randomised controlled trial.
Diabetes doubles the risk of cataract in the general population, with an even greater increased risk among people aged under 70, according to researchers.
Hyper-reflective subretinal infiltrates visible on spectral domain optical coherence tomography (SD-OCT) could help diagnose primary vitreoretinal lymphoma (PVRL), researchers believe.
An artificial vision device (MyEye, OrCam) has helped a blind veteran regain his independence, according to the charity Scottish War Blinded.
Cataract surgery increases the risk of diabetic macular oedema (DMO), medical records from the United Kingdom suggest. An analysis of 4,850 eyes showed that the rate of DMO requiring treatment spiked about 4 months after the surgery.
A low dose of ranibizumab (Lucentis, Genentech/Roche) works well as a treatment for retinopathy of prematurity (ROP), researchers say.
In a world of mass production and high technology, an ocularist in Nottingham, United Kingdom, has inspired followers around the world with his high-touch approach to hand-crafting prosthetic eyes as portrayed in a couple of YouTube videos.
A combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more effective than either one alone in reducing the risk of cystoid macular oedema (CME) after cataract surgery in nondiabetic patients, researchers say.
The European Commission has granted marketing authorisation for cenegermin eye drops (Oxervate, Dompé) for the treatment of moderate to severe neurotrophic keratitis.